Synthetic Biology Innovations Inc. (SBI) is a company at the forefront of synthetic biology, specializing in the design and construction of biological parts, devices, and systems for applications ranging from healthcare to industrial biotechnology.
SBI addresses the need for precise control over biological systems, enabling the creation of novel enzymes, biosensors, and therapeutic proteins with tailored properties that can be used in various applications from drug discovery to environmental remediation.
SBI employs advanced computational methods, including artificial intelligence (AI), machine learning, and high-throughput experimentation to optimize protein structures and genetic circuits. Their workflow involves designing, building, testing, and analyzing these biological components in a modular fashion.
Manufacturing processes include DNA synthesis, cloning, and expression in host cells. These steps are highly regulated to ensure product quality and consistency.
The build process involves computational design of proteins or genetic circuits followed by laboratory validation through transformation into bacterial or yeast hosts for production and characterization.
Field units draw low hundreds of watts; fabrication is energy-intensive due to vacuum baking and high-throughput sequencing processes.
Ranges and qualitative terms only — verify power figures against vendor datasheets.
No companies curated for this tile yet.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.